查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197768

闭塞器械市场——增长、趋势、COVID-19 的影响和预测 (2023-2028)

Occlusion Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，封堵器械市场的复合年增长率预计为 7.5%。

COVID-19 大流行影响了各种外科手术。 在患有各种与生活方式相关的疾病和慢性疾病的患者中，观察到诊断和治疗的延误是由于隔离导致的医院就诊次数减少，从而影响了所研究的市场。 例如，根据 2020 年 8 月发表的一项研究，COVID-19 大流行对加拿大的介入放射学服务产生了负面影响，尤其是择期病例。 调查显示，约49.3%的受访者表示，国内的介入放射服务整体呈下降趋势。 数据显示，大流行减少了手术程序，这影响了封堵器市场。 然而，疫苗接种和 COVID-19 病例数的下降已经完全反弹了所研究的市场。

推动市场增长的主要因素包括微创手术 (MIS) 的接受率高于传统手术、生活方式病和慢性病的增加以及该领域的技术进步。 例如，根据一份 2021 年世卫组织情况说明书，非传染性疾病 (NCD)，也称为慢性病，每年导致约 4100 万人死亡，2021 年全球记录的死亡人数约占所有死亡人数的 71%。 根据同一消息来源，全世界每年有超过 1500 万 30-69 岁的人死于非传染性疾病。 因此，非传染性疾病造成的高死亡负担增加了对治疗的需求。 因此，预计该市场将在预测期内扩大。

MIS 的日益普及预计将推动整个市场的增长。 MIS 的特点是术后疼痛较轻。 此外，凭藉最少的切口和缝合线以及相对较短的住院时间，该技术已证明其在执行复杂手术中的效率。

然而，产品的高成本和对熟练专业人员的需求阻碍了市场的增长。

封堵器市场趋势

神经学领域的预期增长

脑动脉瘤患病率的上升和新技术产品的推出预计将推动整个市场的增长。 根据 Brain Aneurysm Foundation 的估计，到 2021 年，美国每年约有 30,000 人患有脑动脉瘤破裂。

脑动脉瘤的形成因素包括血管损伤/外伤、吸烟、高血压和遗传易感性。 脑动脉瘤的治疗包括药物治疗、手术夹闭或血管内治疗，或者在有或没有辅助装置的情况下进行捲绕。 例如，根据 2021 年 8 月的 WHO Key Facts，全球估计有 12.8 亿 30-79 岁的成年人患有高血压，其中大多数（三分之二）在低收入和中等收入国家。这是增长背后的推动力段的。

根据同一消息来源，尤其是 55 岁以上的女性患脑动脉瘤破裂的风险高于男性。 随着人口老龄化的增加，这种风险预计会在未来增加。 根据联合国2020年发布的数据，全球60岁及以上人口预计将从2020年的13.2%增长到2050年的21.3%。 预计这会增加动脉瘤的发生率。 因此，发病率上升有望帮助市场增长。

预计在预测期内北美将占据最大的市场份额

由于微创手术的普及和医疗基础设施的加强，北美有望成为最大的封堵器市场。 此外，新型封堵器获批的增加也有望推动整体市场增长。 市场参与者 Abbott Laboratories 于 2020 年 11 月获得 FDA 批准的 Amplatzer Piccolo 封堵器，该封堵器用于通过微创手术治疗动脉导管未闭的婴儿。这将是世界上第一个植入式医疗设备。

越来越多的心血管疾病病例也创造了对该产品的需求并促进了市场的增长。 例如，根据美国疾病预防控制中心 2021 年 9 月发布的数据，心脏病是美国的首要死因。 20岁以上成年人约有1820万人患有冠心病，2019年约有36.09万人死于冠心病。 因此，由于该国心血管疾病的死亡率很高，预计手术数量将会增加，这有望促进封堵器的采用并促进市场的增长。

癌症也是该国最常见的慢性病之一，预计未来几年将进一步推动市场增长。 例如，根据 GLOBOCAN 2020 报告，2020 年美国将报告 101,809 例结肠癌病例、44,780 例直肠癌病例和 26,259 例胃癌病例。 预计这将推动该国对干预措施的需求。 因此，由于上述因素，预计市场在预测期内将出现高增长。

封堵器市场竞争对手分析

由于少数主要市场参与者的存在，封堵器市场正在整合。 一些市场参与者是雅培实验室、波士顿科学公司、BTG 国际有限公司、爱德华兹生命科学公司、强生公司、美敦力 PLC、梅里特医疗系统公司、Penumbra Inc.、Stryker Corporation、Penumbra Inc 和 Terumo Corporation。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动因素
    • 越来越多地采用微创手术
    • 不断增长的老年人口和不断增加的慢性病负担
    • 技术进步
  • 市场製约因素
    • 产品成本高
    • 需要熟练的专业人员
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：百万美元）

  • 按产品分类
    • 闭塞去除装置
      • 线圈猎犬
      • 支架回收器
      • 其他
    • 栓塞装置
    • 支持的设备
  • 通过申请
    • 外周血管疾病
    • 神经
    • 肿瘤科
    • 泌尿科
    • 其他应用
  • 最终用户
    • 医院
    • 门诊手术中心
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Abbott Laboratories
    • Boston Scientific Corporation
    • BTG International Ltd
    • Edwards Lifesciences Corporation
    • Johnson & Johnson
    • Medtronic PLC
    • Merit Medical Systems
    • Penumbra Inc.
    • Stryker Corporation
    • Terumo Corporation
    • Lepu Medical Technology
    • LeMaitre Vascular Inc.

第7章 市场机会今后动向

简介目录
Product Code: 66840

The occlusion devices market is expected to register a CAGR of 7.5% during the forecast period.

The COVID-19 pandemic had ramifications on various surgical procedures. Due to the lockdown restrictions, a delay in diagnosis and treatments was observed in patients with various lifestyle-related and chronic diseases as a result of a reduction in hospital visits, which impacted the market studied. For instance, according to the research study published in August 2020, the COVID-19 pandemic negatively impacted interventional radiology services in Canada, especially for elective cases. As per the study, about 49.3% of the respondents reported that there was an overall decline in interventional radiology services in the country. Thus, this data indicates that surgical procedures declined due to the pandemic scenario, which, in turn, affected the occlusion devices market. However, due to the vaccinations and declining cases of COVID-19, the market studied has bounced back to its full potential.

The major factors for the growth of the market include the higher acceptance rate of minimally invasive surgeries (MIS) over traditional surgeries, the increasing prevalence of lifestyle-related and chronic diseases, and technological advancements in the area. For instance, according to the WHO fact sheet of 2021, non-communicable diseases (NCDs), also known as chronic diseases, are responsible for the death of about 41 million people each year, which was about 71% of the total deaths recorded all over the world in 2021. As per the same source, every year, over 15 million people aged between 30-69 die due to NCDs across the world. Therefore, the demand for treatment procedures is increasing owing to the high burden of mortality due to NCDs. Thus, the market studied is expected to grow over the forecast period.

The rising adoption of MIS is expected to drive the overall growth of the market. MIS cause less post-operative pain. Besides, there are minimal cuts or stitches involved, the hospital stay is relatively shorter, and this technology is proving its efficiency in treatment while performing complex surgeries.

However, the high cost of the products and the requirement for skilled professionals are hampering the growth of the market.

Occlusion Devices Market Trends

Neurology Segment is Expected to Witness a Lucrative Growth

The rising prevalence of brain aneurysms and the launch of new technologically advanced products are expected to drive the overall growth of the market. According to 2021 estimates by the Brain Aneurysm Foundation, approximately 30,000 people in the United States suffer a brain aneurysm rupture each year.

Factors contributing to the formation of a brain aneurysm are injury/trauma to blood vessels, smoking, hypertension, and genetic predisposition. The treatment of brain aneurysms includes medical therapy, surgical clipping or endovascular therapy, or coiling without or with adjunctive devices. For instance, as per the WHO's key facts of August 2021, an estimated 1.28 billion adults aged 30-79 years worldwide were living with hypertension, most (two-thirds) living in low- and middle-income countries, which is driving the segmental growth.

The same source stated that women, particularly those over the age of 55, have a higher risk of brain aneurysm rupture than men. This risk is expected to increase in the future as the geriatric population increases. As per the UN data published in 2020, the global population aged 60 years or above is anticipated to increase from 13.2% in 2020 to 21.3% by 2050. This is expected to raise the incidence of aneurysms. Hence, the rising incidence is expected to help the market's growth.

North America is Expected to Hold Largest Market Share over the Forecast Period

North America is expected to be the largest occlusion devices market owing to the rising adoption of minimally invasive surgeries and better healthcare infrastructure. Furthermore, the rising approval of new occlusion devices is expected to boost the overall growth of the market. One of the market players, Abbott Laboratories, received approval from FDA for the Amplatzer Piccolo Occluder in November 2020, which is the world's first medical device that can be implanted in babies using a minimally invasive procedure to treat patent ductus arteriosus.

The increasing cases of cardiovascular diseases are also generating demand for the product, which is fuelling the market's growth. For instance, as per the CDC's data published in September 2021, heart disease was the leading cause of death in the United States. About 18.2 million adults of age 20 years and older had coronary artery disease, and about 360,900 people died in 2019 due to coronary heart disease. Thus, due to the high mortality rate caused by cardiovascular diseases in the country, the number of surgeries is expected to increase, which, in turn, is likely to boost the adoption of occlusion devices, thereby contributing to the market's growth.

In addition, cancer is also one of the most prevalent chronic diseases in the country, which is further expected to augment the growth of the market over the years. For instance, according to the GLOBOCAN 2020 Report, 101,809 cases of colon cancer, 44,780 cases of rectum cancer, and 26,259 cases of stomach cancer were reported in the United States in 2020. This is expected to drive the demand for interventional procedures in the country. Thus, owing to the factors mentioned above, the market is expected to witness high growth over the forecast period.

Occlusion Devices Market Competitor Analysis

The occlusion devices market is consolidated owing to the presence of a few major market players. Some of the market players are Abbott Laboratories, Boston Scientific Corporation, BTG International Ltd, Edwards Lifesciences Corporation, Johnson & Johnson, Medtronic PLC, Merit Medical Systems, Penumbra Inc., Stryker Corporation, Penumbra Inc., and Terumo Corporation.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Adoption of Minimally Invasive Surgeries
    • 4.2.2 Increasing Geriatric Population and Rising Burden of Chronic Diseases
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Products
    • 4.3.2 Requirement of Skilled Professionals
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Occlusion Removal Devices
      • 5.1.1.1 Coil Retrievers
      • 5.1.1.2 Stent Retrievers
      • 5.1.1.3 Other Occlusion Removal Devices
    • 5.1.2 Embolization Devices
    • 5.1.3 Support Devices
  • 5.2 By Application
    • 5.2.1 Peripheral Vascular Disease
    • 5.2.2 Neurology
    • 5.2.3 Oncology
    • 5.2.4 Urology
    • 5.2.5 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 BTG International Ltd
    • 6.1.4 Edwards Lifesciences Corporation
    • 6.1.5 Johnson & Johnson
    • 6.1.6 Medtronic PLC
    • 6.1.7 Merit Medical Systems
    • 6.1.8 Penumbra Inc.
    • 6.1.9 Stryker Corporation
    • 6.1.10 Terumo Corporation
    • 6.1.11 Lepu Medical Technology
    • 6.1.12 LeMaitre Vascular Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS